(Q53374150)
Statements
CD34/CD133 enriched bone marrow progenitor cells promote neovascularization of tissue engineered constructs in vivo. (English)
Marietta Herrmann
Andreas Binder
Ursula Menzel
Mauro Alini
Sophie Verrier
22 October 2014
13
3 Pt A
465-477